Search Results - "Lužnik, M."

P760 Endometriosis mimicking incarcerated hernia during menstruation: A case report by Petković, L., Pristovnik, F., Golob, B. Verdnik, Lužnik, M., Gorjanc, J., Kozar, F.

Get full text

Estimating population size of the cave shrimp Troglocaris anophthalmus (Crustacea, Decapoda, Caridea) using mark–release–recapture data by Jugovic, J., Praprotnik, E., Buzan, E. V., Luznik, M.

“…Population size estimates are lacking for many small cave–dwelling aquatic invertebrates that are vulnerable to groundwater contamination from anthropogenic…”
Get full text

Estimating population size of the cave shrimp Troglocaris anophthalmus (Crustacea, Decapoda, Caridea) using mark–release–recapture data by J. Jugovic, E. Praprotnik, E. V. Buzan, M. Lužnik

“…Estimación del tamaño de la población del camarón cavernícola Troglocaris anophthalmus (Crustacea, Decapoda, Caridea) mediante la utilización de datos de…”
Get full text

Switching on surface conduction in a topological insulator by Taupin, M, Eguchi, G, Luznik, M, Steiger-Thirsfeld, A, Ishida, Y, Kuroda, K, Shin, S, Kimura, A, Paschen, S

“…Phys. Rev. B 107, 235306 (2023) The protected surface conduction of topological insulators is in high demand for the next generation of electronic devices…”
Get full text

Abstract QS37: Induction Of Delayed Immune Tolerance After Reconstructive Transplantation By Combining Donor Bone Marrow Transplantation And High-dose Cyclophosphamide Treatment by GUO, YINAN, Messner, Franka, Oh, Byoung Chol, Furtmüller, Georg J., Lee, W.P. Andrew, Cooney, Damon S., Luznik, Leo, Brandacher, Gerald

Get full text

Post-Transplant Cyclophosphamide Improves Engraftment in Patients with Sickle Cell Disease (SCD) and Severe Organ Damage who Undergo Haploidentical Peripheral Blood Stem Cell Transplantation (PBSCT) by Fitzhugh, Courtney, MD, Hsieh, Matthew, MD, Taylor, Tiffani, PA-C, Coles, Wynona, RRT, Luznik, Leo, MD, Powell, Jonathan, MD, PhD, Tisdale, John F., MD

Get full text

Proteomic Biomarkers Are Predictive of Non-Relapse Mortality in Patients Treated with Post-Transplantation Cyclophosphamide Following HLA-Haploidentical or HLA-Matched-Related or –Unrelated Allogeneic BMT by Kanakry, Christopher G., MD, Bakoyannis, Giorgos, PhD, Perkins, Susan M., PhD, McCurdy, Shannon R., MD, Warren, Edus H., MD, PhD, Vulic, Ante, MD, Daguindau, Etienne, MD, Olmsted, Taylor, MD, Mumaw, Christen, BS, Towlerton, Andrea M., BS, O'Donnell, Paul V., MD, PhD, Symons, Heather J., MD, MHS, Paczesny, Sophie, MD, PhD, Luznik, Leo, MD

Get full text

Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease by Radojcic, Vedran, MD, Chung, Jooho, Friedman, Ann, Reddy, Pavan, MD, Blazar, Bruce R., MD, Luznik, Leo, MD, Brennan, Todd, MD, Siebel, Christian, PhD, Maillard, Ivan, MD, PhD

Get full text

Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies by Symons, Heather J., MD, MHS, Chen, Allen, MD, PhD, MHS, Gamper, Christopher, MD, PhD, Cooke, Kenneth R., MD, Showel, Margaret, MD, MHS, Bolaños-Meade, Javier, MD, Luznik, Leo, MD, Jones, Richard J., MD, Fuchs, Ephraim J., MD, MBA

Get full text

Nonmyeloablative Haploidentical BMT with Post-Transplant Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies by Klein, Orly R., MD, Buddenbaum, Jessica, BS, Tucker, Noah, MM, Chen, Allen R., MD, PhD, MHS, Cooke, Kenneth R., MD, Gamper, Christopher, MD, PhD, Loeb, David, MD, PhD, Zambidis, Elias, MD, PhD, Llosa, Nicolas J., MD, Huo, Jeffrey S., MD, PhD, Robey, Nancy, PA, Holuba, Mary Jo, MSN, RN, CRNP, Kasamon, Yvette L., MD, McCurdy, Shannon R., MD, Ambinder, Richard F., MD, PhD, Meade, Javier Bolanos, Luznik, Leo, MD, Fuchs, Ephraim J., MD, MBA, Jones, Richard J., MD, Symons, Heather J., MD, MHS

Get full text

The Use of Post-Transplantation Cyclophosphamide after Myeloablative, HLA-Matched Allogeneic Bone Marrow Transplantation Minimizes the Need for Additional Immunosuppression by Kanakry, Christopher G., MD, Bolaños-Meade, Javier, MD, Kasamon, Yvette L., MD, Zahurak, Marianna, MS, Durakovic, Nadira, MD, Furlong, Terry, RN, Medeot, Marta, MD, Mielcarek, Marco, MD, Borrello, Ivan M., MD, Brodsky, Robert A., MD, Gladstone, Douglas E., MD, Huff, Carol Ann, MD, Matsui, William H., MD, Swinnen, Lode J., MD, Ambinder, Richard F., MD, PhD, Fuchs, Ephraim J., MD, MBA, de Lima, Marcos, MD, Andersson, Borje S., MD, PhD, Varadhan, Ravi, PhD, O'Donnell, Paul V., MD, PhD, Jones, Richard J., MD, Luznik, Leo, MD

Get full text

Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation by Kanakry, Christopher G., MD, Perkins, Susan M., PhD, Daguindau, Etienne, MD, Vulic, Ante, MD, Olmsted, Taylor, MD, Mumaw, Christen, MS, McCurdy, Shannon R., MD, Symons, Heather J., MD, MHS, Towlerton, Andrea M., BS, Warren, Edus H., MD, PhD, O'Donnell, Paul V., MD, PhD, FACP, Paczesny, Sophie, MD, PhD, Luznik, Leo, MD

Get full text

Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide by McCurdy, Shannon R., MD, Vulic, Ante, MD, Symons, Heather J., MD, MHS, Towlerton, Andrea M., BS, Valdez, Ben C., PhD, Jones, Richard J., MD, Fuchs, Ephraim J., MD, MBA, O'Donnell, Paul V., MD, PhD, FACP, Warren, Edus H., MD, PhD, Kanakry, Christopher G., MD, Luznik, Leo, MD

Get full text

Rarity of Donor-Derived Malignancy after Allogeneic BMT with High-Dose Post-Transplantation Cyclophosphamide by Symons, Heather Jill, MD, MHS, Mogri, Huzefa, BS, Kanakry, Jennifer A., MD, Ambinder, Richard, MD, PhD, Luznik, Leo, MD, Fuchs, Ephraim J., MD, Jones, Richard J., MD, Kasamon, Yvette L., MD

Get full text

Extended Follow-up of Myeloablative, HLA-Matched Allogeneic BMT with High-Dose, Post-Transplantation Cyclophosphamide (PTCy) As Sole GVHD Prophylaxis: Favorable Outcomes Despite Low Incidence of Chronic GVHD by Kanakry, Christopher G., MD, Tsai, Hua-Ling, MS, Bolaños-Meade, Javier, MD, Smith, B Douglas, MD, Gojo, Ivana, MD, Kasamon, Yvette L., MD, Kanakry, Jennifer A., MD, Zahurak, Marianna, MS, Fuchs, Ephraim J., MD, Jones, Richard J., MD, Luznik, Leo, MD

Get full text